Dr Cranston Jay Cederlind, MD | |
421 S Maple St, Garnett, KS 66032-1334 | |
(785) 448-3131 | |
(785) 448-5725 |
Full Name | Dr Cranston Jay Cederlind |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | 421 S Maple St, Garnett, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821070905 | NPI | - | NPPES |
100333710B | Medicaid | KS | |
160053740 | Other | KS | RAILROAD MEDICARE |
614623 | Other | KS | FIRSTGUARD HEALTH PLAN |
09194024 | Other | MO | BCBS OF KANSAS CITY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 04-15034 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Cranston Jay Cederlind, MD Po Box 14095, Shawnee Mission, KS 66285-4095 Ph: (913) 888-6310 | Dr Cranston Jay Cederlind, MD 421 S Maple St, Garnett, KS 66032-1334 Ph: (785) 448-3131 |
News Archive
Sangamo BioSciences, Inc. announced the initiation of two new clinical trials of ZFP Therapeutics, a Phase 2b study in diabetic neuropathy (DN) and a Phase 1 trial in glioblastoma, as well as the renewal of $3.0 million in funding for the Phase 2b trial by the Juvenile Diabetes Research Foundation International (JDRF).
Move over, salamanders, we humans can also regrow some of our body tissues. At least, this is what a new study published on October 9, 2019, in the journal Science Advances, reports. Using a mechanism quite similar to that by which amphibians like salamanders, and some zebrafish, grow back lost body parts, human joint cartilage can also regenerate itself.
Researchers studying two generations of a family affected by pediatric acute lymphoblastic leukemia (ALL) have identified an inherited variation in the ETV6 gene that is associated with an increased risk of developing the disease. St. Jude Children's Research Hospital investigators led the study, which appears in the October 28 issue of the journal Lancet Oncology.
Significant decreases in CT imaging for cancer persisted even after the peak of the COVID-19 pandemic in 2020, delaying diagnosis and treatment and raising the possibility of more advanced cancers and poorer outcomes for patients in the future, according to a study being presented next week at the annual meeting of the Radiological Society of North America.
› Verified 4 days ago